| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8434bbf341b1e7c0630b52714cae43f6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-20022 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate |
2002-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66d6323afe62be3117bc469c43c2850a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_717a9313e232a907e926ab6de640a1c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_888b2cb16c77b7c769853837102d0381 |
| publicationDate |
2003-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003050469-A1 |
| titleOfInvention |
Induction of a Th1-like response in vitro |
| abstract |
The invention provides compositions and methods for stimulating a Th1-like response in vitro. Compositions include fusion proteins and conjugates that contain at least a portion of a heat shock protein. A Th1-like response can be elicited by contacting in vitro a cell sample containing naive lymphocytes with a fusion protein or conjugate of the invention. The Th1-like response can be detected by measuring IFN-gamma produced by the cell sample. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8835619-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017200489-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007160621-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7622121-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8227207-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006280804-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010136016-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11421000-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3458058-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2017265263-B2 |
| priorityDate |
1999-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |